Unitary patent opt-out misery; Delaware filing trends; first German life sciences AASI; Amgen v Sanofi ruling; USPTO fee hike; plus much more
Everything we covered on IAM over the last seven days – and all you need to know from the global IP market to set yourself up for the start of another busy week.
MONDAY 15 May
UPC system experiencing severe problems as patentees race to opt out their rights. Read more here
IAM-Docket Navigator report: Patent holders flee Delaware as disclosure orders continue to bite. Read more here
TUESDAY 16 May
SCOTUS turns down much-watched ‘skinny label’ appeal in blow to generic drug companies. Read more here
US PTAB ruling shakes ground of VLSI’s $2.18 billion patent verdict. Read more here
WEDNESDAY 17 May
Long read: Efficient IP management in a market increasingly using open source. Read more here
A briefing on the US IP enforcement coordinator as Deborah Robinson nominated for post. Read more here
THURSDAY 18 May
Weekly column: The BlackBerry patent sale is a missed opportunity for company and country. Read more here
German court issues first ever AASI in life sciences case. Read more here
Timeline of allegations against Federal Circuit Judge Pauline Newman. Read more here
FRIDAY 19 May
UPC central division will have branch in Milan, Italian government announces. Read more here
Patent holders critical of some proposed USPTO fee hikes geared to changing filing behaviour. Read more here
Five key takeaways from SCOTUS’ landmark Amgen v Sanofi enablement ruling. Read more here
SATURDAY 20 May
Opinion: USPTO’s new Catch-22 targets Unified Patents in standing requirement reforms. Read more here